Stress Hyperglycemia. Potential Role of Incretin Analogs
NCT ID: NCT01087372
Last Updated: 2010-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2010-01-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia
NCT00362778
Diabetes Mellitus After Intensive Care Admission
NCT02180555
Blood Glucose Management in Intensive Care Units
NCT05775770
Hypoglycemia and the Mineralocorticoid Receptor
NCT01394627
Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest
NCT01968148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Emergent ICU admission
* Written informed consent from patient or relative.
Exclusion Criteria
* Patients who received insulin or oral antidiabetic agents before ICU admission.
* Malignancies.
* Scheduled surgery
* Patients receiving enteral or parenteral nutrition.
* Inability to obtain informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Mateu Orfila
UNKNOWN
Hospital Universitari Son Dureta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital Universitari Son Dureta
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan A Llompart-Pou, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitari Son Dureta. Intensive Care Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Son Dureta. Intensive Care Unit
Palma de Mallorca, Balearic Islands, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Llompart-Pou JA, Fernandez-de-Castillo AG, Burguera B, Perez-Barcena J, Marse P, Rodriguez-Yago M, Barcelo A, Raurich JM. Stress hyperglycaemia in critically ill patients: potential role of incretin hormones; a preliminary study. Nutr Hosp. 2012 Jan-Feb;27(1):130-7. doi: 10.1590/S0212-16112012000100015.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Incretins2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.